Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Leet DE"'
Autor:
Mennillo E, Lotstein ML, Lee G, Johri V, Ekstrand C, Tsui J, Hou J, Leet DE, He JY, Mahadevan U, Eckalbar W, Oh DY, Fragiadakis GK, Kattah MG, Combes AJ
Publikováno v:
BioRxiv : the preprint server for biology [bioRxiv] 2024 Nov 11. Date of Electronic Publication: 2024 Nov 11.
Autor:
Leet DE; Division of Gastroenterology, Department of Medicine, University of California, San Francisco, San Francisco, California, USA., Wen KW; Division of Gastrointestinal-Hepatobiliary Pathology, Department of Pathology, University of California, San Francisco, San Francisco, California, USA.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California, USA., Kouanda A; Division of Gastroenterology, Department of Medicine, University of California, San Francisco, San Francisco, California, USA.
Publikováno v:
The American journal of gastroenterology [Am J Gastroenterol] 2024 Oct 17. Date of Electronic Publication: 2024 Oct 17.
Autor:
Badran YR; Division of Gastroenterology, Department of Internal Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, MA, USA., Zou F; Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Department of Oncology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, People's Republic of China., Durbin SM; Harvard Medical School, Boston, MA, USA.; Department of Internal Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA., Dutra BE; Department of Internal Medicine, The University of Texas Health Science Center at Houston, Houston, Texas, USA., Abu-Sbeih H; Department of Internal Medicine, University of Missouri Kansas City, Kansas City, Missouri, USA., Thomas AS; Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Altan M; Department of Thoracic, Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Thompson JA; Department of Medicine, Division of Oncology, Fred Hutchinson Cancer Research Center, Seattle Cancer Care Alliance, University of Washington, Seattle, Washington, USA., Qiao W; Department of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Leet DE; Harvard Medical School, Boston, MA, USA.; Department of Internal Medicine, University of California San Francisco, San Francisco, California, USA., Lai PY; Biostatistics Center, Massachusetts General Hospital, Boston, MA, USA., Horick NK; Biostatistics Center, Massachusetts General Hospital, Boston, MA, USA., Postow MA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Department of Medicine, Weill Cornell Medical Center, New York, New York, USA., Faleck DM; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA mldougan@partners.org YWang59@mdanderson.org faleckd@mskcc.org.; Department of Medicine, Weill Cornell Medical Center, New York, New York, USA., Wang Y; Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA mldougan@partners.org YWang59@mdanderson.org faleckd@mskcc.org., Dougan M; Division of Gastroenterology, Department of Internal Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA mldougan@partners.org YWang59@mdanderson.org faleckd@mskcc.org.; Harvard Medical School, Boston, MA, USA.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2023 Jun; Vol. 11 (6).
Autor:
Hu Z; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Leet DE; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Allesøe RL; Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Oliveira G; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Li S; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA, USA., Luoma AM; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA., Liu J; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA., Forman J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA, USA., Huang T; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA, USA., Iorgulescu JB; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA., Holden R; Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA, USA., Sarkizova S; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Gohil SH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Academic Haematology, University College London, London, UK., Redd RA; Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA, USA., Sun J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Elagina L; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Giobbie-Hurder A; Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA, USA., Zhang W; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Peter L; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA., Ciantra Z; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Rodig S; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Olive O; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Shetty K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Pyrdol J; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA., Uduman M; Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Lee PC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA., Bachireddy P; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA., Buchbinder EI; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA., Yoon CH; Harvard Medical School, Boston, MA, USA.; Department of Surgery, Brigham and Women's Hospital, Boston, MA, USA., Neuberg D; Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA, USA., Pentelute BL; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Chemistry, Massachusetts Institute of Technology, Cambridge, MA, USA.; The Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA., Hacohen N; Harvard Medical School, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Center for Cancer Research, Massachusetts General Hospital, Boston, MA, USA., Livak KJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA, USA., Shukla SA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA, USA., Olsen LR; Section for Bioinformatics, Department of Health Technology, Technical University of Denmark, Lyngby, Denmark.; Center for Genomic Medicine, Copenhagen University Hospital, Copenhagan, Denmark., Barouch DH; Harvard Medical School, Boston, MA, USA.; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA.; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA., Wucherpfennig KW; Harvard Medical School, Boston, MA, USA.; Department of Cancer Immunology and Virology, Dana-Farber Cancer Institute, Boston, MA, USA., Fritsch EF; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA., Keskin DB; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA, USA., Wu CJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA., Ott PA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. patrick_ott@dfci.harvard.edu.; Harvard Medical School, Boston, MA, USA. patrick_ott@dfci.harvard.edu.; Broad Institute of MIT and Harvard, Cambridge, MA, USA. patrick_ott@dfci.harvard.edu.; Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA. patrick_ott@dfci.harvard.edu.
Publikováno v:
Nature medicine [Nat Med] 2021 Mar; Vol. 27 (3), pp. 515-525. Date of Electronic Publication: 2021 Jan 21.
Autor:
Thompson LL; Department of Medicine, Division of Hematology & Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02114, USA., Katznelson E; Department of Medicine, Division of Hematology & Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02114, USA., Leet DE; Department of Medicine, Division of Hematology & Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02114, USA., Durbin SM; Department of Medicine, Division of Hematology & Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02114, USA., Yoon J; Department of Medicine, Division of Hematology & Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02114, USA., Reynolds KL; Department of Medicine, Division of Hematology & Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02114, USA., Dougan ML; Department of Medicine, Division of Gastroenterology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02114, USA., Chen ST; Department of Medicine, Division of Hematology & Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA 02114, USA; Department of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA. Electronic address: stchen@partners.org.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2021 Jan; Vol. 142, pp. 143-146. Date of Electronic Publication: 2020 Oct 22.
Autor:
Badran YR; Department of Medicine, Massachusetts General Hospital , Boston, MA, USA.; Medical Student, Harvard Medical School , Boston, MA, USA., Leet DE; Medical Student, Harvard Medical School , Boston, MA, USA., Dougan M; Medical Student, Harvard Medical School , Boston, MA, USA.; Division of Gastroenterology, Department of Medicine, Massachusetts General Hospital , Boston, MA, USA.
Publikováno v:
Expert review of anticancer therapy [Expert Rev Anticancer Ther] 2020 Sep; Vol. 20 (9), pp. 727-730. Date of Electronic Publication: 2020 Sep 01.
Autor:
Hu Z; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Anandappa AJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA., Sun J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Kim J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Leet DE; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA., Bozym DJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA., Chen C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Williams L; Broad Institute of MIT and Harvard, Cambridge, MA., Shukla SA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Broad Institute of MIT and Harvard, Cambridge, MA.; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA., Zhang W; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Tabbaa D; Broad Institute of MIT and Harvard, Cambridge, MA., Steelman S; Broad Institute of MIT and Harvard, Cambridge, MA., Olive O; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Livak KJ; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, MA., Kishi H; Department of Immunology, University of Toyama, Toyama, Japan., Muraguchi A; Department of Immunology, University of Toyama, Toyama, Japan., Guleria I; Department of Pathology, Brigham and Women's Hospital, Boston, MA., Stevens J; Department of Pathology, Brigham and Women's Hospital, Boston, MA., Lane WJ; Harvard Medical School, Boston, MA.; Department of Pathology, Brigham and Women's Hospital, Boston, MA., Burkhardt UE; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Fritsch EF; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Broad Institute of MIT and Harvard, Cambridge, MA., Neuberg D; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA., Ott PA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA; and., Keskin DB; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; Broad Institute of MIT and Harvard, Cambridge, MA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA; and., Hacohen N; Harvard Medical School, Boston, MA.; Broad Institute of MIT and Harvard, Cambridge, MA.; Massachusetts General Hospital, Boston, MA., Wu CJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; Broad Institute of MIT and Harvard, Cambridge, MA.; Department of Medicine, Brigham and Women's Hospital, Boston, MA; and.
Publikováno v:
Blood [Blood] 2018 Nov 01; Vol. 132 (18), pp. 1911-1921. Date of Electronic Publication: 2018 Aug 27.
Autor:
Agarwal I; Department of Biology, Amherst College, Massachusetts 01002., Farnow C; Department of Biology, Amherst College, Massachusetts 01002., Jiang J; Program in Biochemistry and Biophysics, Amherst College, Massachusetts 01002., Kim KS; Department of Biology, Amherst College, Massachusetts 01002., Leet DE; Department of Biology, Amherst College, Massachusetts 01002., Solomon RZ; Department of Biology, Amherst College, Massachusetts 01002., Hale VA; Department of Biology, Amherst College, Massachusetts 01002., Goutte C; Department of Biology, Amherst College, Massachusetts 01002 cegoutte@amherst.edu.; Program in Biochemistry and Biophysics, Amherst College, Massachusetts 01002.
Publikováno v:
Genetics [Genetics] 2018 Feb; Vol. 208 (2), pp. 745-762. Date of Electronic Publication: 2017 Dec 14.